Why insider trading matters?

Numerous studies have examined whether there is evidence that U.S. insiders systematically trade on private information despite the legal deterrence. The consensus appears to be that insider purchases (but not sales) tend to be followed by positive abnormal stock price performance, particularly for small growth stocks.

- Prof. B. Espen Eckbo, Dartmouth College
Coherus BioSciences, Inc. (CHRS)
Sector: Healthcare; Industry: Biotechnology

Coherus BioSciences, Inc., a commercial-stage biotherapeutics company, focuses on the biosimilar market worldwide. It markets UDENYCA, a long-acting granulocyte-colony stimulating factor, which stimulates production of granulocytes in order to promote the body's ability to fight infections. The company sells UDENYCA in the United States. Coherus BioSciences, Inc. has collaboration and license agreements with Daiichi Sankyo Company, Limited; Baxalta Incorporated; Baxalta US Inc.; Baxalta GmbH; and Selexis SA.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2019-12-16 Anicetti Vincent R Chief Operating Officer Sell 2,500 $18.69 $46,725 Yes
2019-11-21 Lanfear Dennis M President & CEO Sell 12,500 $18.56 $231,960 No
2019-11-20 Lanfear Dennis M President & CEO Sell 825,000 $18.00 $14,850,000 No
2019-11-20 Viret Jean-Frederic Chief Financial Officer Sell 3,159 $19.59 $61,872 Yes
2019-11-18 Viret Jean-Frederic Chief Financial Officer Sell 3,112 $18.88 $58,757 No
2019-11-14 Anicetti Vincent R Chief Operating Officer Sell 2,500 $19.26 $48,150 Yes
2019-10-18 Viret Jean-Frederic Chief Financial Officer Sell 1,388 $19.02 $26,400 No
2019-10-16 Viret Jean-Frederic Chief Financial Officer Sell 3,159 $19.00 $60,021 Yes
2019-10-14 Anicetti Vincent R Chief Operating Officer Sell 2,500 $18.40 $46,000 Yes
2019-09-23 Viret Jean-Frederic Chief Financial Officer Sell 740 $21.78 $16,117 No
2019-09-18 Viret Jean-Frederic Chief Financial Officer Sell 3,159 $20.44 $64,560 Yes
2019-09-16 Anicetti Vincent R Chief Operating Officer Sell 2,500 $20.03 $50,075 Yes
2019-08-21 Viret Jean-Frederic Chief Financial Officer Sell 6,318 $21.71 $137,154 Yes
2019-08-19 Viret Jean-Frederic Chief Financial Officer Sell 3,000 $19.04 $57,120 No
2019-08-14 Anicetti Vincent R Chief Operating Officer Sell 2,500 $19.00 $47,500 Yes
2019-07-15 Anicetti Vincent R Chief Operating Officer Sell 2,500 $19.20 $48,000 Yes
2019-07-02 HEALY JAMES Director Sell 360,000 $22.30 $8,027,600 No
2019-06-20 HEALY JAMES Director Sell 317,130 $21.37 $6,777,068 No
2019-06-19 Viret Jean-Frederic Chief Financial Officer Sell 6,826 $19.85 $135,514 Yes
2019-05-30 Lanfear Dennis M President & CEO Sell 32,398 $19.49 $631,282 No
2019-05-22 HEALY JAMES Director Sell 257,870 $20.69 $5,335,330 No
2019-03-20 Viret Jean-Frederic Chief Financial Officer Sell 3,000 $14.92 $44,762 No
2018-09-10 FINCK BARBARA K Chief Medical Officer Sell 1,760 $18.58 $32,699 Yes
2018-08-29 HEALY JAMES Director Sell 25,000 $20.50 $512,500 No
2018-08-13 FINCK BARBARA K Chief Medical Officer Sell 1,760 $19.02 $33,480 Yes
2018-07-23 Viret Jean-Frederic Chief Financial Officer Sell 9,291 $18.56 $172,472 No
2018-07-10 FINCK BARBARA K Chief Medical Officer Sell 1,760 $15.01 $26,415 Yes
2018-06-18 FINCK BARBARA K Chief Medical Officer Sell 1,760 $15.00 $26,400 Yes
2018-05-16 Lanfear Dennis M See Remarks Sell 20,984 $16.26 $341,265 No
2017-08-08 Herman Alan C. Chief Scientific Officer Sell 17,535 $15.02 $263,300 No

Insider Smart

Mohawk Group Holdings, Inc. (MWK) - Multiple insiders bought MWK in June around $5, stock moved sideways for a month then made a 60% jump in 10 days. Patience is the key.

Insider Smart

SIMON PROPERTY GROUP (SPG) - Bottom fishing the crash could be intimidating, but it can be easier if you know insiders are on your side. Aeppel Glyn, Director of SPG played safe and bought shares in May at $50, but it is not late at all, the stock is now $90.